Colonial Trust Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$606K Sell
2,786
-106
-4% -$23.5K 0.05% 136
2025
Q4
$661K Buy
2,892
+83
+3% +$18.9K 0.05% 137
2025
Q3
$650K Sell
2,809
-138
-5% -$28.1K 0.05% 140
2025
Q2
$547K Buy
2,947
+220
+8% +$40.9K 0.05% 141
2025
Q1
$571K Buy
2,727
+137
+5% +$26.6K 0.05% 136
2024
Q4
$460K Sell
2,590
-143
-5% -$26.3K 0.04% 146
2024
Q3
$540K Buy
2,733
+6
+0.2% +$1.12K 0.05% 142
2024
Q2
$468K Sell
2,727
-192
-7% -$31.8K 0.04% 131
2024
Q1
$532K Buy
2,919
+75
+3% +$12.9K 0.05% 130
2023
Q4
$441K Hold
2,844
0.05% 140
2023
Q3
$424K Sell
2,844
-4
-0.1% -$587 0.05% 142
2023
Q2
$384K Hold
2,848
0.04% 152
2023
Q1
$454K Sell
2,848
-9
-0.3% -$1.38K 0.05% 144
2022
Q4
$462K Hold
2,857
0.06% 143
2022
Q3
$383K Buy
2,857
+760
+36% +$109K 0.05% 146
2022
Q2
$321K Hold
2,097
0.05% 140
2022
Q1
$340K Buy
2,097
+28
+1% +$4.07K 0.04% 151
2021
Q4
$280K Hold
2,069
0.03% 162
2021
Q3
$223K Hold
2,069
0.03% 176
2021
Q2
$233K Sell
2,069
-100
-5% -$11.3K 0.03% 178
2021
Q1
$235K Sell
2,169
-7
-0.3% -$749 0.03% 172
2020
Q4
$233K Buy
+2,176
New +$209K 0.03% 158

Other funds holding ABBV

Colonial Trust Advisors's ABBV Position: Q1 2026 in Review

Colonial Trust Advisors reduced its AbbVie (ABBV) stake by 3.7% in Q1 2026, selling an estimated $23.5K and leaving 2,786 shares worth $606K. The position accounts for 0.05% of the portfolio, ranked #136.

Colonial Trust Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $661K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Colonial Trust Advisors held 2,786 shares of AbbVie worth $606K as of Q1 2026.
  • Colonial Trust Advisors sold 106 AbbVie shares in Q1 2026, an estimated $23.5K.
  • AbbVie made up 0.05% of Colonial Trust Advisors's portfolio in Q1 2026, its #136 holding.
  • Colonial Trust Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Colonial Trust Advisors's AbbVie position peaked at $661K in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.